Showing results (151-160 of 578) with videos related to
Sort By:
Pageof 58
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
The pharmacology of selegiline ((-)deprenyl). New aspectsJ KnollActa Neurologica Scandinavica. Supplementum|January 1, 1989
Pharmacokinetics and metabolism of selegilineE H Heinonen, V Myllylä, K Sotaniemi, et al.Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH)G J Birkmayer, W BirkmayerActa Neurologica Scandinavica. Supplementum|January 1, 1989
Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?M B Youdim, D Ben-Shachar, P RiedererActa Neurologica Scandinavica. Supplementum|January 1, 1989
Objective measurement of motor disability in Parkinson's diseaseG Steg, P E Ingvarsson, B Johnels, et al.Acta Neurologica Scandinavica. Supplementum|January 1, 1982
Organic brain syndromes from a psychiatric point of view: diagnostic and nosological aspectsM OlkinuoraActa Neurologica Scandinavica. Supplementum|January 1, 1982
Electrophysiological investigation of toxic neuropathiesP M Le QuesneActa Neurologica Scandinavica. Supplementum|January 1, 1994
Effects of arginine, S-adenosylmethionine and polyamines on nerve regenerationB CestaroActa Neurologica Scandinavica. Supplementum|January 1, 1994
S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studiesG M BressaActa Neurologica Scandinavica. Supplementum|February 27, 2003
Cognitive deficits in preclinical Alzheimer's diseaseBrent J Small, Jennifer L Mobly, Erika Jonsson Laukka, et al.Pageof 58